A disease model resource reveals core principles of tissue-specific cancer evolution

S Sebastian Mueller N Niklas de Andrade Krätzig M Markus Tschurtschenthaler M Miguel G. Silva C Chiara Thordsen R Riccardo Trozzo P Perrine Simon F Frederic Saab T Thorsten Kaltenbacher M Magdalena Zukowska D Daniele Lucarelli R Rupert Öllinger J Joscha Griger N Nina Groß T Tanja Groll J Jessica Löprich A Antonio E. Zaurito L Linus R. Schömig J Jeroen M. Bugter S Stefanie Bärthel C Chiara Falcomatà A Alexander Strong C Cordelia Brandt M Mulham Najajreh A Aristeidis Papargyriou R Roman Maresch K Katharina A. N. Collins D David Sailer C Christian Schneeweis S Sebastian Burger L Lisa M. Fröhlich C Christine Klement A Alexander Belka J Juan J. Montero U Ute Jungwirth M Maximilian Reichert M Markus Moser J Jens Neumann G George Vassiliou J Juan Cadiñanos I Ignacio Varela C Carsten Marr D Daniel F. Alonso P Pier-Luigi Lollini J Jean Zhao L Louis Chesler C Clare M. Isacke A Angela Riedel C Christian J. Braun M Martin L. Sos F Filippo Beleggia H Hans C. Reinhardt M Monica Musteanu M Mariano Barbacid M Michael Quante M Marc Schmidt-Supprian G Günter Schneider S Simon Clare T Trevor D. Lawley G Gordon Dougan K Katja Steiger N Nathalie Conte A Allan Bradley L Lena Rad D Dieter Saur R Roland Rad

Abstract

Abstract Oncogenes such as KRAS display marked tissue specificity in their oncogenic potential, genetic interactions and phenotypic effects, but the underlying determinants remain largely unresolved 1–5 . Here, to address these questions, we developed the Mouse Cancer Cell line Atlas, a broad-utility resource of 590 comprehensively characterized models across a wide range of entities ( www.mcca.tum.de ). Comparative and functional studies using this platform, human cohorts and mice identified core principles underlying tissue-specific evolution of KRAS -initiated cancers. First, we show that mutant KRAS dosage gain through allelic imbalance exerts cell-type-specific effects, defining its timing across entities, as exemplified by dosage-sensitive developmental reprogramming during pancreatic cancer initiation. Second, we highlight how tissue- and stage-specific evolutionary requirements, such as block of differentiation in the intestine, select for KRAS -collaborating alterations. Third, we identified context-dependent epistatic KRAS –tumour suppressor interactions and show that reciprocal dosage sensitivities dictate the entity-specific patterns of cancer gene alterations, explaining their frequency, zygosity and acquisition chronology. These findings highlight how intrinsic and acquired determinants instruct cancer evolution in different tissues, with predictable molecular patterns, temporal dynamics and phenotypic outcomes. Our study provides major advances towards a mechanistic understanding of cancer genomes.

Article Details

Journal Nature
Volume / Issue Vol. 653, Issue 8113
Published May 07, 2026
ISSN 0028-0836
Publisher Nature Portfolio

Journal Info

Nature

Nature Portfolio

ISSN: 0028-0836 Health Sciences

Authors (66)

S

Sebastian Mueller

N

Niklas de Andrade Krätzig

M

Markus Tschurtschenthaler

M

Miguel G. Silva

C

Chiara Thordsen

R

Riccardo Trozzo

P

Perrine Simon

F

Frederic Saab

T

Thorsten Kaltenbacher

M

Magdalena Zukowska

D

Daniele Lucarelli

R

Rupert Öllinger

J

Joscha Griger

N

Nina Groß

T

Tanja Groll

J

Jessica Löprich

A

Antonio E. Zaurito

L

Linus R. Schömig

J

Jeroen M. Bugter

S

Stefanie Bärthel

C

Chiara Falcomatà

A

Alexander Strong

C

Cordelia Brandt

M

Mulham Najajreh

A

Aristeidis Papargyriou

R

Roman Maresch

K

Katharina A. N. Collins

D

David Sailer

C

Christian Schneeweis

S

Sebastian Burger

L

Lisa M. Fröhlich

C

Christine Klement

A

Alexander Belka

J

Juan J. Montero

U

Ute Jungwirth

M

Maximilian Reichert

M

Markus Moser

J

Jens Neumann

G

George Vassiliou

J

Juan Cadiñanos

I

Ignacio Varela

C

Carsten Marr

D

Daniel F. Alonso

P

Pier-Luigi Lollini

J

Jean Zhao

L

Louis Chesler

C

Clare M. Isacke

A

Angela Riedel

C

Christian J. Braun

M

Martin L. Sos

F

Filippo Beleggia

H

Hans C. Reinhardt

M

Monica Musteanu

M

Mariano Barbacid

M

Michael Quante

M

Marc Schmidt-Supprian

G

Günter Schneider

S

Simon Clare

T

Trevor D. Lawley

G

Gordon Dougan

K

Katja Steiger

N

Nathalie Conte

A

Allan Bradley

L

Lena Rad

D

Dieter Saur

R

Roland Rad